https://orcid.org/0000-0002-3189-6810
References
- Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984;64(1):1–12. doi:10.1182/blood.V64.1.1.1
- Landolfi R, Rocca B, Patrono C. Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment. Crit Rev Oncol Hematol 1995;20(3):203–222. doi:10.1016/1040-8428(94)00164-O
- Barbui T, Carobbio A, Cervantes F, Vannucchi AM, Guglielmelli P, Antonioli E, Alvarez-Larrán A, Rambaldi A, Finazzi G, Barosi G, et al. Thrombosis in primary myelofibrosis: incidence and risk factors. Blood 2010;115(4):778–782. doi:10.1182/blood-2009-08-238956
- Falanga A, Marchetti M. Thrombosis in myeloproliferative neoplasms. Semin Thromb Hemost 2014;40(3):348–358. doi:10.1055/s-00000077
- Rozman C, Giralt M, Feliu E, Rubio D, Cortes MT. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991;67(10):2658–2663. doi:10.1002/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C
- Akay OM. The double hazard of bleeding and thrombosis in hemostasis from a clinical point of view: a global assessment by rotational thromboelastometry (ROTEM). Clin Appl Thromb Hemost 2018;24(6):850–858. doi:10.1177/1076029618772336
- Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allaouchiche B, Negrier C. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007;5(2):289–295. doi:10.1111/jth.2007.5.issue-2
- Gunduz E, Akay OM, Bal C, Gulbas Z. Can thrombelastography be a new tool to assess bleeding risk in patients with idiopathic thrombocytopenic purpura? Platelets 2011;22(7):516–520. doi:10.3109/09537104.2011.571317
- Espinosa A, Stenseth R, Videm V, Pleym H. Comparison of three point-of-care testing devices to detect hemostatic changes in adult elective cardiac surgery: a prospective observational study. BMC Anesthesiol 2014:1480.
- Jeong SM, Song JG, Seo H, Choi JH, Jang DM, Hwang GS. Quantification of both platelet count and fibrinogen concentration using maximal clot firmness of thromboelastometry during liver transplantation. Transplant Proc 2015;47(6):1890–1895. doi:10.1016/j.transproceed.2015.02.019
- Peng HT, Nascimento B, Beckett A. Thromboelastography and thromboelastometry in assessment of fibrinogen deficiency and prediction for transfusion requirement: a descriptive review. Biomed Res Int 2018:20187020539.
- Lier H, Vorweg M, Hanke A, Gorlinger K. Thromboelastometry guided therapy of severe bleeding. Essener Runde algorithm. Hamostaseologie 2013;33(1):51–61. doi:10.5482/HAMO-12-05-0011
- Akay OM, Ustuner Z, Canturk Z, Mutlu FS, Gulbas Z. Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Med Oncol 2009;26(3):358–364. doi:10.1007/s12032-008-9129-0
- Lim HY, Ng C, Rigano J, Tacey M, Donnan G, Nandurkar H, Ho P. An evaluation of global coagulation assays in myeloproliferative neoplasm. Blood Coagul Fibrinolysis 2018;29(3):300–306. doi:10.1097/MBC.0000000000000724
- Tripodi A, Chantarangkul V, Gianniello F, Clerici M, Lemma L, Padovan L, Gatti L, Mannucci PM, Peyvandi F Global coagulation in myeloproliferative neoplasms. Ann Hematol 2013;92(12):1633–1639. doi:10.1007/s00277-013-1834-x
- Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis. Blood 2013;122(13):2176–2184. doi:10.1182/blood-2013-03-460154